Which of the following drugs should not be administered concomitantly with warfarin as it decreases the effect of oral anticoagulants?
## **Core Concept**
The question tests the interaction between warfarin, a commonly used oral anticoagulant, and other drugs that can alter its effect. Warfarin works by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver. Drugs that induce or inhibit the cytochrome P450 system or affect vitamin K metabolism can alter warfarin's anticoagulant effect.
## **Why the Correct Answer is Right**
The correct answer, , is rifampicin. Rifampicin is a potent inducer of the cytochrome P450 enzyme system, particularly the CYP3A4 and CYP2B6 isoenzymes, which are involved in the metabolism of warfarin. By inducing these enzymes, rifampicin increases the metabolism of warfarin, leading to decreased warfarin levels and a reduced anticoagulant effect. This can result in a decreased International Normalized Ratio (INR) and potentially lead to thrombotic events.
## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option does not specify a drug and is therefore cannot be evaluated.
* **Option B:** - Without a specified drug, this option cannot be assessed for its accuracy in relation to warfarin interaction.
* **Option D:** - Similarly, this option lacks a specific drug to evaluate its interaction with warfarin.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that rifampicin, due to its potent enzyme-inducing properties, can significantly decrease the effects of many drugs, including warfarin, oral contraceptives, and certain antiretroviral drugs. Clinicians should be cautious when co-prescribing rifampicin with drugs that have narrow therapeutic indices.
## **Correct Answer: C. Rifampicin**